This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Eli Lilly and Company, Deciphera Pharmaceuticals, LLC. Active years: 2014-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 4,514 
1 out of 99 Years Active: 2014-2024
Title: The Innovations of Matthew Carl Allgeier
Introduction
Matthew Carl Allgeier is a notable inventor based in Fishers, IN (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 3 patents. His work primarily focuses on developing innovative pharmaceutical compositions aimed at treating various diseases.
Latest Patents
Among his latest patents, Allgeier has developed solid oral fixed dose compositions that combine metformin, atorvastatin, and valsartan, or their pharmaceutically acceptable salts. These compositions are designed to enhance treatment efficacy for specific health conditions. The processes for preparing these compositions are also detailed in his patents, showcasing his commitment to advancing pharmaceutical science.
Career Highlights
Throughout his career, Allgeier has worked with prominent companies in the pharmaceutical industry, including Eli Lilly and Company and Deciphera Pharmaceuticals, LLC. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research and development in the field.
Collaborations
Allgeier has collaborated with talented individuals such as Tony Yantao Zhang and Daniel L Flynn. These partnerships have further enriched his work and expanded the impact of his inventions.
Conclusion
Matthew Carl Allgeier's contributions to pharmaceutical innovations demonstrate his dedication to improving healthcare through science. His patents reflect a commitment to developing effective treatments for patients in need.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile